Samotolisib
Product Specifications
CAS Number
1386874-06-1
Target
PI3K, DNA-PK, Autophagy, mTOR
Related Pathways
PI3K/Akt/mTOR signaling, DNA Damage/DNA Repair, Autophagy
Purity
0.9971
Bioactivity
Samotolisib (LY3023414) is an oral ATP competitive inhibitor of the class I PI3K isoforms, DNA-PK, and mTOR. Samotolisib (LY3023414) has been used in trials studying the treatment of Neoplasm, Solid Tumor, COLON CANCER, BREAST CANCER, and Advanced Cancer, among others.
Smiles
COC(C)Cn1c2c(cnc3ccc(cc23)-c2cncc(c2)C(C)(C)O)n(C)c1=O
Molecular Formula
C23H26N4O3
Molecular Weight
406.48
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1023048-01 0.5 mg (E-Coli)
Recombinant Haemophilus influenzae Protein tonB (tonB), partial
Sign In for Pricing
View Details MBS1023048-02 0.05 mg (Baculovirus)
Recombinant Haemophilus influenzae Protein tonB (tonB), partial
Sign In for Pricing
View Details MBS1023048-03 0.5 mg (Yeast)
Recombinant Haemophilus influenzae Protein tonB (tonB), partial
Sign In for Pricing
View Details MBS1023048-04 0.05 mg (Mammalian-Cell)
Recombinant Haemophilus influenzae Protein tonB (tonB), partial
Sign In for Pricing
View Details MBS1023048-05 1 mg (E-Coli)
Recombinant Haemophilus influenzae Protein tonB (tonB), partial
Sign In for Pricing
View Details MBS1023048-06 0.1 mg (Baculovirus)
Recombinant Haemophilus influenzae Protein tonB (tonB), partial
Sign In for Pricing
View Details